Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3778
|
pubmed:dateCreated |
1967-7-1
|
pubmed:abstractText |
The excretion of oxypurine metabolites in urine of patients with congenital hyperuricosuria exceeds, on a creatinine basis, that observed in any previously recognized metabolic anomaly. The ratio of hypoxanthine to xanthine is from 2:1 to 3:1 and results from increased hypoxanthine excretion, in contrast to other hyperuricosuric conditions where ratios of less than one have been reported. Administration of allopurinol (a xanthine-oxidase inhibitor) reduces the excretion of uric acid but results in an equivalent increase in xanthine and hypoxanthine. These features appear to be unique to congenital hyper-uricosuria.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0036-8075
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1122-3
|
pubmed:dateRevised |
2007-8-17
|
pubmed:meshHeading |
pubmed-meshheading:6024192-Allopurinol,
pubmed-meshheading:6024192-Child,
pubmed-meshheading:6024192-Child, Preschool,
pubmed-meshheading:6024192-Humans,
pubmed-meshheading:6024192-Hypoxanthines,
pubmed-meshheading:6024192-Purine-Pyrimidine Metabolism, Inborn Errors,
pubmed-meshheading:6024192-Uric Acid,
pubmed-meshheading:6024192-Xanthines
|
pubmed:year |
1967
|
pubmed:articleTitle |
Urinary metabolites in congenital hyperuricosuria.
|
pubmed:publicationType |
Journal Article
|